ARTICLE | Distillery Therapeutics
PCF11 binding site on E3 ubiquitin ligase MAGEA11 identified as neuroblastoma target
October 27, 2020 8:19 PM UTC
DISEASE CATEGORY: Cancer
INDICATION: Neuroendocrine tumors...
BCIQ Company Profiles
DISEASE CATEGORY: Cancer
INDICATION: Neuroendocrine tumors...
BCIQ Company Profiles